Incyte Corp

13F Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 4.37M shares
Security Ownership: 9.9%

INCYTE CORP ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)

2025-11-07 - INCYTE CORP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.37M shares of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD). This represents 9.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
INCYTE CORP	9.9%		$6.3M	4.37M			$1.44	13G	11/3/2025	7 Nov 2025 16:01:48